Abstract
The recent pandemic of 2009 H1N1 influenza lead to higher rates of severe infection (including hospitalisation and death) in those with chronic illness and immunocompromise including HIV. A strain specific vaccine was introduced in the UK in October 2009. The Department of Health (DoH) issued guidelines to GPs on the correct use of seasonal and pandemic H1N1 vaccine in HIV infected individuals, however uptake was anecdotally poor. We aimed to quantify uptake within our HIV cohort using questionnaires during the pandemic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
